This topic contains a solution. Click here to go to the answer

Author Question: A patient with hypertension is prescribed terazosin (Hytrin). When should you administer the first ... (Read 45 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
A patient with hypertension is prescribed terazosin (Hytrin). When should you administer the first dose of this drug to the patient?
 
  a. In the morning to avoid waking the patient at night
  b. With meals to avoid GI problems
  c. With a full glass of water
  d. At bedtime

Question 2

You are teaching a patient who has just been prescribed prazosin (Minipress) for hypertension. You immediately notify the prescriber and question the order upon discovering that the patient is also taking which drug?
 
  a. Aspirin
  b. Atenolol (Tenormin)
  c. Chlorothiazide (Diuril)
  d. Sildenafil (Viagra)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nixon_s

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

ANS: D

Answer to Question 2

ANS: D




corkyiscool3328

  • Member
  • Posts: 539
Reply 2 on: Jul 24, 2018
Gracias!


JCABRERA33

  • Member
  • Posts: 344
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library